143 related articles for article (PubMed ID: 12915667)
1. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
Quinkler M; Meyer B; Oelkers W; Diederich S
J Clin Endocrinol Metab; 2003 Aug; 88(8):3767-72. PubMed ID: 12915667
[TBL] [Abstract][Full Text] [Related]
2. Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites.
Quinkler M; Johanssen S; Grossmann C; Bähr V; Müller M; Oelkers W; Diederich S
J Clin Endocrinol Metab; 1999 Nov; 84(11):4165-71. PubMed ID: 10566667
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
[TBL] [Abstract][Full Text] [Related]
4. Difference of in vivo and in vitro antimineralocorticoid potency of progesterone.
Quinkler M; Diederich S
Endocr Res; 2002 Nov; 28(4):465-70. PubMed ID: 12530650
[TBL] [Abstract][Full Text] [Related]
5. Progestogens with antimineralocorticoid activity.
Losert W; Casals-Stenzel J; Buse M
Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
[TBL] [Abstract][Full Text] [Related]
6. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I; Cutler GB
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[TBL] [Abstract][Full Text] [Related]
7. 11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy.
Walker BR; Williamson PM; Brown MA; Honour JW; Edwards CR; Whitworth JA
Hypertension; 1995 Apr; 25(4 Pt 1):626-30. PubMed ID: 7721407
[TBL] [Abstract][Full Text] [Related]
8. Endogenous renal 11 beta-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension.
Takeda Y; Miyamori I; Iki K; Inaba S; Furukawa K; Hatakeyama H; Yoneda T; Takeda R
Hypertension; 1996 Feb; 27(2):197-201. PubMed ID: 8567041
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
[TBL] [Abstract][Full Text] [Related]
10. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
Ehrlich EN; Lindheimer MD
J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
[TBL] [Abstract][Full Text] [Related]
11. Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis.
Quattropani C; Vogt B; Odermatt A; Dick B; Frey BM; Frey FJ
J Clin Invest; 2001 Nov; 108(9):1299-305. PubMed ID: 11696574
[TBL] [Abstract][Full Text] [Related]
12. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
13. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
[TBL] [Abstract][Full Text] [Related]
14. Impaired renal 11 beta-oxidation of 9 alpha-fluorocortisol: an explanation for its mineralocorticoid potency.
Oelkers W; Buchen S; Diederich S; Krain J; Muhme S; Schöneshöfer M
J Clin Endocrinol Metab; 1994 Apr; 78(4):928-32. PubMed ID: 8157723
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid synthesis during the periovulatory interval in macaques.
Fru KN; VandeVoort CA; Chaffin CL
Biol Reprod; 2006 Oct; 75(4):568-74. PubMed ID: 16837642
[TBL] [Abstract][Full Text] [Related]
16. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
[TBL] [Abstract][Full Text] [Related]
17. Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by diuretics and the renin-angiotensin-aldosterone axis.
Ricketts ML; Stewart PM
Clin Sci (Lond); 1999 Jun; 96(6):669-75. PubMed ID: 10334975
[TBL] [Abstract][Full Text] [Related]
18. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
Oelkers W; Berger V; Bolik A; Bähr V; Hazard B; Beier S; Elger W; Heithecker A
J Clin Endocrinol Metab; 1991 Oct; 73(4):837-42. PubMed ID: 1890155
[TBL] [Abstract][Full Text] [Related]
19. The role of progesterone metabolism and androgen synthesis in renal blood pressure regulation.
Quinkler M; Diederich S; Bähr V; Oelkers W
Horm Metab Res; 2004 Jun; 36(6):381-6. PubMed ID: 15241728
[TBL] [Abstract][Full Text] [Related]
20. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
